Literature DB >> 6248200

Effect of subcutaneously administered 2,6,10,14-tetramethylpentadecane on plasmacytoma growth.

M Platica, C Bojko, G Steiner, V P Hollander.   

Abstract

2,6,10,14-Tetramethylpentadecane (pristane), s.c. injected simultaneously with plasmacytoma inocula, enhances the transplantability of tumor cells. The effect is dose and time dependent. The enhancement is shown only by plasmacytoma (MOPC-315 and MPC-11) and not by the murine lymphosarcoma and chondrosarcoma tested. Various mechanisms, such as stress and depression of humoral and cellular immunity, have been considered.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248200

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  Changes in the DNA of lymphocytes from pristane treated rats.

Authors:  L R Garrett; K L Bost; T M Buttke; M A Cuchens
Journal:  Agents Actions       Date:  1987-02

2.  Adjuvants- and vaccines-induced autoimmunity: animal models.

Authors:  Jiram Torres Ruiz; Luis Luján; Miri Blank; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 4.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.